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1 
INTRODUCTION 
2,4,9
 
                  In recent years, caesarean section has been one of the commonly 
performed surgeries in the world. 
         The pain caused by caesarean section is usually moderate to severe for the 
first two to three postoperative days. This pain can interfere with the mother-
child bonding, breast feeding and care. Also the immobility caused may 
predispose to deep vein thrombosis. 
       So the postoperative analgesia should alleviate all these ill effects of pain 
and should be safe for both mother and baby. 
        This is accomplished by a multimodal analgesia in which opioids are 
routinely used. But opioids have many side effects like vomitting, sedation, 
respiratory depression etc. A parturient should be rendered free of these side 
effects too. Thus we should use analgesic techniques that reduce opioid 
requirement. 
         The pain associated with LSCS may be somatic and visceral.The major  
component is from the abdominal wall incision(i.e somatic). 
           A technique of regional anaesthesia called the transversus abdominis 
plane (TAP) block ,blocks the afferents from the nerves supplying anterior 
abdominal wall (T6-L1) and can relieve this incisional pain. 
 
 
2 
         The Transversus abdominis plane is situated in between the internal 
oblique and transversus abdominis muscle. It contains the nerve fibres 
supplying anterior abdominal wall and can be blocked by local anaesthetics. 
           Mc donnell et al conducted a study and demonstrated the efficacy of 
TAP block in reducing morphine consumption after abdominal surgeries. 
           Another meta analysis proved that, in addition to effective pain relief 
,the requirement of opioids and their side effects were reduced by TAP block. 
          TAP block done under USG guidance have the additional advantage of 
monitoring the needle course and the spread of local anaesthetic solution which 
helps in improving safety and efficacy of the block. 
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AIM  AND OBJECTIVES OF THE STUDY 
 
AIM  
      5. To evaluate postoperative IV/IM analgesic initiation time           
                    
 
 
 
 
 
       To compare post operative analgesia using Ropivacaine (0.5%) and 
Bupivacaine (0.25%) in bilateral transversus abdominis plane block after spinal 
anaesthesia for lower segment caesarean section . 
 
SECONDARY OBJECTIVES  
1. To evaluate the duration of post operative analgesic efficacy of these 
drugs. 
2. To assess  postoperative  haemodynamics. 
3. Post operative visual analogue scale pain score. 
4. Complication rate. 
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                            ULTRASOUND IN ANAESTHESIA 
27,28
 
 
           The technology of ultrasound in medicine has evolved leaps and bounds 
over the years. 
           The ultrasound imaging can play a major role in the field of 
Anaesthesiology, critical care and pain to perform with precision and to reduce 
complications. 
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PHYSICS OF ULTRASOUND 
             Sound is produced when mechanical energy travels through matter as a 
wave, producing alternate compression and rarefaction. Ultrasound imaging is 
based on the scattering of sound energy by interfaces formed of materials of 
different properties. The amplitude of reflected energy is used to generate 
ultrasound images. 
           Frequencies used in ultrasound are higher than those in the audible range 
and typically vary from 2-15 MHz for diagnostic procedures. 
 
                                          Electrical energy 
                                                    ↓ 
                                                                                                             SOUND 
                                
                                                   ↑ 
                                       Electrical energy 
 
PARTS OF ULTRASOUND 
1) TRANSDUCER  
2) RECEIVER AND PROCESSOR 
3) IMAGE DISPLAY 
        
          Piezoelectric crystal 
 
 
6 
 
 
 
1)TRANSDUCER: 
Converts electrical energy to mechanical energy & vice versa.                                                  
 
2)RECEIVER AND PROCESSOR 
These detect and amplify the backscattered energy and manipulate the reflected 
signals for display. 
 
3)IMAGE  DISPLAY 
           Earliest A mode devices displayed the voltage produced across the 
transducer as a vertical deflection. 
          Only the position and strength of reflection of a structure could be 
recorded. 
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         M mode displays echo amplitude and shows the position of moving 
reflectors. 
         Real time B mode display uses multiple ultrasound pulses to generate a 
two dimensional image. 
 
PROPAGATION OF ULTRASOUND: 
            Ultrasound transducers work on the principle of piezo electricity. 
Within the transducer are arrays of piezoelectric crystals, which have the 
property of changing shape  when an electrical voltage is applied. 
            The sound wave propagates through the body tissues and interactions 
occur between the wave and the tissues. 
            The waves that are reflected back to the transducer strike the 
piezoelectric crystal. The crystal converts sound into electrical energy. 
            Air and bone have different impedence compared to other tissues. 
Hence ultrasound cannot be used to image deep to bone or air. 
 
RESOLUTION: 
            Refers to ability of the device to differentiate two closely situated 
objects or distinct objects  
TYPES 
         Axial Resolution: Measured along the axis of the ultrasound beam in its 
direction of  propagation. 
       Transverse resolution: Measured at 90
0 
 to axial resolution 
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        Axial resolution is always superior. 
        High frequency transducers produce higher resolution images but the 
sound waves are absorbed more. 
        Low frequency transducers have greater penetration but poor resolution. 
APPLICATON OF ULTRASOUND IN ANAESTHESIA: 
                  1. Ultrasound for vascular access 
                  2. Ultrasound guided regional anaesthesia 
                  3. Trans-esophageal echocardiography 
                  4. Echocardiogram 
ULTRASOUND GUIDED PERIPHERAL NERVE BLOCKS: 
      ADVANTAGES:  
                     1. Direct visualisation of neural structures. 
                     2. Direct visualisation of related structures like blood vessels and 
tendons which helps to identify nerves. 
                     3. Guidance of the needle under  real time visualisation. 
 
                     4. Monitor the spread of local anaesthetic. 
                     5. Avoid complications like intravascular and intraneuronal 
injection. 
                     6. Allows repositioning of the needle after an initial injection to 
allow better delivery of local anaesthetics. 
                      7. Can be used in patients with poor twitch response to nerve 
stimulation. 
                      8. In fixing catheter for postop analgesia. 
                       9. Complications are less in USG guided peripheral nerve blocks 
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                                 ANATOMY 
2,4,16
 
  
 
 
 
              Innervation of the anterolateral abdominal wall arises from the anterior 
rami of spinal nerves T7 to L1. These include the intercostal nerves (T7-T11), 
the subcostal nerve (T12), and the iliohypogastric and ilioinguinal nerves (L1). 
 
             The anterior divisions of T7-T11 continue from the intercostal space to 
enter the abdominal wall between the internal oblique and transversus 
abdominis muscles until they reach the rectus abdominis, which they perforate 
and supply, ending as anterior cutaneous branches supplying the skin of the 
front of the abdomen. Midway in their course they pierce the external oblique 
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muscle giving off the lateral cutaneous branch which divides into anterior and 
posterior branches that supply the external oblique muscle and latissimus dorsi 
respectively.   
             
             The anterior branch of T12 communicates with the iliohypogastric 
nerve and gives a branch to the pyramidalis. Its lateral cutaneous branch 
perforates the internal and external oblique muscles and descends over the iliac 
crest and supplies sensation to the front part of the gluteal region.   
                
              The Iliohypogastric nerve (L1) divides between the internal oblique 
and transversus abdominis near the iliac crest into lateral and anterior 
cutaneous branches, the former supplying part of the skin of the gluteal region 
while the latter  supplies the hypogastric region.   
 
            The Ilioinguinal nerve (L1) communicates with the iliohypogastric 
nerve between the internal oblique and transversus abdominis near the anterior 
part of the iliac crest. It supplies the upper and medial part of the thigh and part 
of the skin covering the genitalia. 
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LUMBAR TRIANGLE OF PETIT 
16
 
 
              The lower lumbar triangle of petit is a deficiency in the anterior 
abdominal muscle wall,situated in the midaxillary line between iliac crest and 
lower costal margin.                  
             The triangle is bounded anteriorly by lateral border of external oblique 
muscle and posteriorly by the lateral border of latissimus dorsi. 
             External oblique aponeurosis,internal oblique and transversus 
abdominis forms the base of the triangle. It gives charecteristic `POP OFF` feel 
during blind method of TAP block. 
             It is not uncommon for the triangle of petit to be quite small or poorly 
defined wherein it is suggested to insert the needle 2.5cm  behind the highest 
point of iliac crest. 
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            TRANSVERSUS ABDOMINIS PLANE BLOCK
7,8,26,29
 
 
            The Transversus Abdominis Plane (TAP) Block is a local anaesthetic 
block used to provide analgesia to the anterior and lateral abdominal wall. 
INDCATIONS OF TAP BLOCK: 
TAP block has been recommended as an analgesia for lower abdomnal 
surgeries  like 
 Hernia repair 
 Open appendicectomy 
 Lower segment Caesarean section. 
 Total abdominal hysterectomy 
 Radical prostatectomy 
 Laproscopic cholecystectomy 
 
CONTRAINDICATIONS FOR TAP BLOCK: 
ABSOLUTE: 
 Patient refusal 
 Allergy to local anaesthetic 
 Localised infection over the injection port 
RELATIVE: 
 Coagulopathy 
 Surgery at injection site 
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COMPLICATIONS: 
TAP block is a relatively safe technique with only a few case reports of 
complications. They are 
 Failure 
 Local anaesthetic toxicity 
 Intraperitoneal injection 
 Bowel injury 
 Hepatic injury 
 
 
TECHNIQUE: 
The aim of the TAP block is to deposit a large volume of local anaesthetic 
into the transversus abdominis plane with at least 20 ml of solution being for 
used each side. The concentration of solution used will depend on the 
calculated maximum dose of local anaesthetic allowed. 
General Preparation:  
• Full resuscitation equipment 
 • Patient monitoring (ECG, pulse oximeter, BP) 
 • Antiseptic skin preparation and sterile gloves  
 • Short bevel (300)block needle (50 – 100 mm), or 16-G Tuohy needle 
 • 20 ml syringe 
 • Local anaesthetic  
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LANDMARK TECHNIQUE: 
 
 
 
 Identify the triangle of petit using the anatomical landmarks.  
 A depression can sometimes be palpated between the 
posterior border of the external oblique muscle and the 
anterior border of the latissimus dorsi muscle.  
 As a guide this normally found in the region of  posterior 
axillary line, directly above the iliac crest. 
 Insert the needle perpendicular to the skin.  
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 After piercing the skin, the needle is advanced until a 
„pop‟ is felt - this is the needle piercing the fascial 
extension of the external oblique muscle. 
 The needle should be advanced until a second ‟pop‟ is felt, 
as the needle passes through the fascial extension of the 
internal oblique muscle. 
  The needle should now lie superficial to the transversus 
abdominis muscle, in the transversus abdominis plane  
 After aspiration, to exclude malposition of the needle tip, 
the local anaesthetic is injected. A minimum of 20 ml of 
local anaesthetic per side should be used. 
 Be careful not to exceed the maximum safe dose of local 
anaesthetic 
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Figure showing the entry point for the TAP block.  
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ULTRASOUND GUIDED TECHNIQUE:
7,26
 
                                     
PREPARATION : 
 As for the landmark technique 
 Ultrasound machine   
 High frequency (6-13MHz) linear array probe with probe 
cover and sterile gel. 
 An  assistant to perform injection of the local anaesthetic 
(optional)   
TECHNIQUE: 
 The ultrasound transducer is positioned horizontally across 
the abdomen. 
 The muscle layers in the anterolateral part of the abdomen 
can be traced by scanning from the midline towards the area 
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between the iliac crest and the costal margin, in the mid-
axillary line. 
 
 The ultrasound transducer is moved to scan laterally where 
the 3 muscle layers can be seen running parallel to one 
another.  
 With an adequate ultrasound image, the regional block 
needle is inserted anterior to the transducer. This allows an 
in plane view of the needle as you pierce the transversus 
abdominis plane.  
 The local anaesthetic is then slowly injected. If the needle is 
correctly positioned, the fascial plane is seen to separate and 
form a well-defined, hypoechoic, elliptical image between 
the internal oblique and transversus abdominis muscles. 
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 It is essential to watch for the spread of local anaesthetic 
solution in the correct plane. 
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           PHARMACOLOGY OF  BUPIVACAINE  
1,3,4,6,33                                                               
 
 
Bupivacaine is a long acting amino amide group of  local anaesthetic agent.       
Synthesized by A.F.Ekenstam in 1957 and brought into clinical use in 1963.          
 
 It is produced  in a racemic mixture, containing equal proportions of the 
 S and R  enantiomers. It is supplied for clinical use as a hydrochloride 
 salt. 
                          
CHEMICAL NAME: 1- Butyl-2`6`pipecoloxylidide monohydrochloride 
monohydrate 
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NATURE: White crystalline powder. 
 
SOLUBILITY:  Freely soluble in ethanol and water.Minimally soluble in 
acetone 
CHEMICAL STRUCTURE: 
 
 
 
PHYSICO-CHEMICAL PROFILE  
Molecular weight (base)  - 288  
pKa                                  - 8.1  
 pH                                   -4.5-6.0 
 
MECHANISM OF ACTION: 
                          Local anaesthetic crosses the cell membrane 
                                                    ↓ 
                   Inhibition of sodium channel from cytoplasmic side 
                                                    ↓ 
                        Inhibition of propagation of action potential 
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This occurs by decrease in or prevention of the large transient increases in 
permeability of the cell membrane to sodium ions . 
Bupivacaine also reduces the permeability of the resting nerve membrane to 
potassium as well as sodium ions. 
 
 
 
PHARMACOKINETICS: 
Volume Of Distribution :- 73 Litres 
Elimination Half Life :- 210 Mins 
Clearance :- 0.58 Litres/Min 
Plasma Protein Binding :- 95% 
 Lipid solubility:-28% 
Metabolism:-     -Mainly  By  Liver Microsomal Enzymes  
                          - Aromatic hydroxylation, 
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                          -  N-dealkylation to N –desbutyl bupivacaine 
                          - Amide hydrolysis  
                           - Conjugation. 
        Only the N-dealkylated metabolite  N-desbutyl bupivacaine   
has been measured in blood and urine after epidural and spinal 
administration. 
Excretion:   Through Kidneys. Less than 10% of the drug is excreted                            
unchanged in urine. Renal disease is   unlikely to alter  the 
kinetics after peripheral nerve blockade. 
                      Onset of blockade:-Usually occurs in 20-30 mins 
                      Duration: 8-9 hours 
 
The determinants of the duration are 
 
I. The rate of clearance of the local anesthetics drug :- Rate of clearance 
depends upon the blood supply of  the local  tissue. Hydrophobic drugs 
produce longer blockade due to slower clearance. 
II. Drug dosage:- Larger the dose  of drug, longer the duration of the 
blockade.  This is understood by the longer time needed to clear the 
larger  amount of drug injected 
III. Addition of additives 
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CLINICAL APPLICATIONS : 
 
 
 
PREPARATIONS AVAILABLE  
                  -0.5% Bupivacaine(5mg/ml) and 80 mg dextrose in 4 ml ampoules 
for intrathecal injection . 
                  -0.5% Bupivacaine  solution in 20 ml vial with 8mg sodium 
chloride and 1mg methylparaben as preservative. 
ADVERSE REACTIONS 
It is mainly due to sudden rise in plasma concentrations secondary to accidental 
intravascular administration, increased rate of absorption and decreased clearance 
rate. 
CNS COMPLICATIONS:  
1.Excitation or depression. 
2.Nervousness, dizziness 
3.Blurred vision,  tremors 
4. Drowsiness, convulsions 
5. Unconsciousness, respiratory arrest 
6.Nausea, vomiting, chills 
7.Miosis  of the pupils, or tinnitus 
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CVS COMPLICATIONS: 
1.Depression of the myocardium 
2.Hypotension 
 3.Cardiac arrest.  
 Hypersensitivity, idiosyncrasy, diminished tolerance, urticaria, edema are the 
other adverse reactions. 
 
SYSTEMIC TOXICITY: 
               CC/CNS ratio: Ratio of dosage required for irreversible 
cardiovascular collapse (CC) and Central nervous system(CNS)toxicity. 
 
CONTRAINDICATIONS:- 
Known history of Hypersensitivity to amide local anaesthetics or other 
components of Bupivacaine solutions 
Obstetric Para cervical block with higher concentrations due to risk of fetal 
bradycardia and cardiac arrest 
 
 
 
 
 
 
26 
         PHARMACOLOGY OF ROPIVACAINE 
4,11,19,20,31,33,35
 
  
            Ropivacaine  is a new aminoamide local anaesthetic.  
            One of  the  pipecoloxylidides,introduced  in 1992 . 
             It is a single “S” enantiomer with an enantiometric purity of 99.5%. 
                                       
CHEMICAL NAME: 
            (S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide 
CHEMICAL STRUCTURE: 
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PHYSICOCHEMICAL PROFILE  
Molecular weight (base) - 274  
pKa  (25˚C)                     -8.1  
Lipid solubility                - 6.1  
Plasma protein binding     -94% 
 Water partition coefficient  -2.9   
PHARMACOKINETICS: 
              In terms of lipid solubility , it is 2-3 times less than bupivacaine 
             When compared to Bupivacaine, Ropivacaine  has a smaller volume of  
distribution, greater clearance, and shorter elimination  half-life. 
             It undergoes hepatic biotransformation by cytochrome P450 and only a 
minor proportion is excreted unchanged in urine.   
PHARMACOKINETIC PROFILE : 
Volume of distribution     - 59±7 litres  
Clearance                          -0.82±0.16 l /min  
Elimination half life         -111± 62 min. 
 Metabolism                    - It is rapidly cleared from plasma and it is extensively 
metabolised by cytochrome P450 to 2‟6‟-pipecoloxylidide[PPX], 3‟-OH  
ropivacaine and 4‟-OH ropivacaine. 
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USES: 
                   -Peripheral nerve blocks  
                  -Central neuraxial blocks  
                   -Infiltration anaesthesia 
ADVANTAGES OF ROPIVACAINE : 
              The stereospecificity of s-ropivacaine decreases cardiotoxicity. 
              Both  Bupivacaine and Ropivacaine molecules have chiral centers. 
Commercial bupivacaine is a 50:50 racemic mixture of the S- and R- 
enantiomers.  
              R-enantiomer has greater affinity  at voltage-gated  sodium channels 
and confers greater cardiotoxicity  
              Also  Compared to the S-enantiomer, R-bupivacaine binds three times  
more firmly to the sodium channel, and unbinds 4.4 times as slowly.It is also 
more arrhythmogenic, and slows ventricular conduction 4.6  times as much as 
S-bupivacaine.  
             But Ropivacaine is manufactured as the pure S- enantiomer ,so it has 
decreased cardiotoxicity. 
 
NEGATVE INOTROPY: 
              Compared to bupivacaine, Ropivacaine has a smaller direct negative 
inotropic and arrhythmogenic effect.   
               In a study where  the effect of bupivacaine and ropivacaine on 
multiple electrophysiologic parameters in isolated Purkinje fiber-ventricular 
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muscle were measured ,it showed that bupivacaine produced much more 
depression of cardiac excitability and conduction. 
              In addition, bupivacaine induced electrophysiological alterations can 
make re-entrant type ventricular arrhythmias more likely.Some other studies 
suggest that direct myocardial toxicity of ropivacaine is about half that of 
bupivacaine.  
 
REDUCED CNS  TOXICITY:  
                        Convulsions are less likely with ropivacaine and produce only 
mild CNS effects like light headedness, tinnitus, tongue numbness. If 
convulsions occur, they are of shorter duration than produced by bupivacaine 
and resuscitation is almost always effective if started immediately. 
 
PREPARATIONS  AVAILABLE: 
0.5% Ropivacaine in 10 ml and 20 ml ampoules 
0.75%  Ropivacaine in 4, 10 and 20 ml ampoules.  
1%   Ropivacaine in 10 ml ampoule  
Recommended Safe Dose: 3.5mg/kg    
 
 
 
 
                          
 
 
30 
                       REVIEW OF LITERATURE 
 
1) Uma Srivastava,et al 
36 
(Sep 2015) conducted a double-blind, randomized 
trial to evaluate the  Efficacy of transverse abdominis plane block for post 
cesarean delivery analgesia.  
          62 parturients undergoing caesarean section were randomized in a 
double-blind manner to receive either bilateral TAP block at the end of surgery 
with 20 ml of 0.25% bupivacaine or no TAP block, in addition to standard 
analgesic comprising 75 mg diclofenac 8 hourly and intravenous patient-
controlled analgesia (PCA) tramadol. 
                Each patient was assessed at 0, 4, 8, 12, 24, 36, and 48 hr after 
surgery by an independent observer for pain at rest and on movement using 
numeric rating scale of 0-10, time of 1st demand for tramadol, total 
consumption of PCA tramadol, satisfaction with pain management and side 
effects. 
                 The results were use of tramadol was reduced in patients given TAP 
block by 50% compared to patients given no block during 48 hr after surgery 
(P < 0.001). Pain scores were lower both on rest and activity at each time point 
for 24 hr in study group (P < 0.001), time of first analgesia was significantly 
longer, satisfaction was higher, and side effects were less in study group 
compared to control group.  
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2) Ryoko Kawahara et al
30
(March,2015) conducted a randomised control trial 
regarding  the analgesic efficacy of ultrasound (US)-guided TAP block with the 
mid-axillary approach and was investigated in patients undergoing laparoscopic 
gynaecologic surgery. 
               Adult patients (n = 119) undergoing laparoscopic gynaecologic 
surgery were randomized to undergo either TAP block with ropivacaine (Group 
A, n = 60) or that with saline (Group B, n = 59), in a blinded manner. 
Following general anesthesia, TAP block was performed bilaterally by infusion 
of either 20-mL 0.375% ropivacaine/one side in Group A or 20-mL saline/one 
side in Group B, under US guidance with a mid-axillary approach.   Patient-
controlled analgesia (PCA) was performed postoperatively with tramadol. 
             The analgesic effect was postoperatively evaluated using a four-grade 
pain score and the prince Henry pain scale (PHS) at 0, 6, 12, and 24 hr. 
Postoperative tramadol PCA consumption and vomiting/nausea were recorded. 
Statistical analyses were performed using the Mann-Whitney U-test or Fisher‟s 
exact probability test. A P < 0.05 was considered significant. 
                The dose of remifentanil was significantly higher in Group B (P = 
0.01). The pain score (P = 0.02) and PHS (P = 0.01) were significantly lower in 
Group A at 0 h. Tramadol PCA consumption in the period of 0-6 h (P = 0.01) 
and postoperative nausea (P = 0.04) were significantly less in Group A. 
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         Thus they concluded Postoperative pain/nausea and PCA consumption 
were significantly lower in patients with TAP block in the early postoperative 
stage. TAP block with a mid-axillary approach holds considerable promise as a 
part of a balanced postoperative analgesic regimen following laparoscopic 
gynaecologic surgery. 
 
3)Neha Fuladi et al
23
, (April,2014)did a comparative study of bupivacaine 
0.25% versus ropivacaine 0.5% in transversus abdominis plane block for 
postoperative analgesia in lower abdominal surgeries. 
They evaluated the efficacy of unilateral TAPB with bupivacaine and 
ropivacaine for postoperative analgesia in lower abdominal surgeries like 
hernia repair, appendicectomy in a hospital based, single blind, and 
prospective, randomized controlled clinical trial. 75 adult patients undergoing 
elective unilateral lower abdominal surgery were randomized to undergo TAPB 
with ropivacaine (n = 25) or bupivacaine (n = 25) or Normal saline (n = 25). At 
end of surgery performed under spinal anaesthesia unilateral TAPB on side of 
surgery was performed using 20 ml of 0.5 % ropivacaine or 0.25 % 
bupivacaine or saline. Each patient was assessed postoperatively by a blinded 
investigator in post-anaesthesia care unit every 5 minutes for half an hour, then 
every 15 minutes till 2 hours and at 4, 6, 12, 24, 48 hours postoperatively in 
ward. The results were Mean duration of analgesia was 420.6 minutes with SD 
of +14.01 in Bupivacaine group and 2187 minutes with SD of +1011.09 in 
Ropivacaine group which was found to be statistically significant. Hence they 
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concluded that 0.5% ropivacaine provided longer duration of analgesia than 
0.25 % bupivacaine when used in TAPB on patients of lower abdominal 
surgeries. There were no complications attributable to TAPB or drugs under 
study. 
 
4)Abdallahet al
10
,(Aug,2012)conducted a study regarding the analgesic utility 
of transversus abdominis plane (TAP) block after Caesarean delivery. This 
systematic review and meta-analysis examined whether TAP block can reduce 
i.v. morphine consumption in the ﬁrst 24 hr after CD. The authors retrieved 
randomized controlled trials comparing TAP block with placebo in CD. 
Postoperative i.v. morphine consumption during the ﬁrst 24 hr was selected as 
a primary outcome. Pain scores and both maternal and neonatal opioid-related 
side-effects were secondary outcomes. Where possible, meta-analytic 
techniques and random effects modelling were used to combine data. 
         Trials were stratiﬁed based on whether or not spinal morphine was used 
as part of the analgesic regimen. Five trials including 312 patients were 
identiﬁed. TAP block reduced the mean 24 hr i.v. morphine consumption by 24 
mg [95% conﬁdence interval (CI) 239.65 to 27.78] when spinal morphine was 
not used. TAP block also reduced visual analogue scale pain scores (10 cm line 
where 0 cm, no pain, and 10 cm, worst pain) by 0.8 cm (95% CI 21.53 to 
20.05, P¼0.01), and decreased the incidence of opioid-related side- effects. The 
differences in primary and secondary outcomes were not signiﬁcant when 
spinal morphine was used. 
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        TAP block provides superior analgesia compared with placebo and can 
reduce the ﬁrst 24 hour morphine consumption in the setting of a multimodal 
analgesic regimen that excludes spinal morphine. TAP block can provide 
effective analgesia when spinal morphine is contraindicated or not used. 
 
5) Hyun Jun Shin et al
13
, (2011) conducted a study in which about 32 patients 
were randomised into 2 groups, one undergoing Transverse Abdominis Plane 
block and the other not receiving this  block.  
          Patients were operated under general anaesthesia and block performed 
under ultrasonogram guidance after surgery and prior to extubation. About 
20ml of 0.375% ropivacaine was given bilaterally. Postoperative pain relief 
was given by intravenous Patient Controlled Analgesia containing ketorolac 
90mg, sufentanyl 200μg and ramosetron 0.3mg in 120ml of NS totally for the 
first 24 hours. Fentanyl was given when pain scores were very high.  
         Pain scores were 3.6±2.3 at the end of 10 hours in control group whereas 
2.3±2.4 in Transverse Abdominis Plane group with rest. Total analgesic 
requirements were 62.5±35.4μg of fentanyl in control group and 20.3±20.9μg 
in Transverse Abdominis Plane group.  
        It was concluded that Transverse Abdominis Plane block has some opioid 
sparing action and reduced postoperative pain. It also improved patient 
satisfaction when multimodal analgesic regimen used and also no serious 
complications were associated with this method. 
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6) )  Rao V Kadam et al
8
,(2011) Conducted a study in which 20 patients were 
randomly allocated into two groups – Transverse Abdominis Plane group and 
control group. The study was conducted to evaluate the efficacy of ultrasound 
guided Transverse Abdominis Plane block, comparing with patient controlled 
analgesia with fentanyl in patients undergoing major abdominal surgeries.    
            Both groups were done under General anaesthesia and Transverse 
Abdominis Plane block was given at the end of the surgery under ultrasound 
guidance and an epidural catheter placed within the plane.  
            Transverse Abdominis Plane group received 15ml of 0.5% ropivacaine 
initial bolus bilaterally followed by continuous infusion of 8 – 10ml of 0.2% 
ropivacaine for next 72 hours. Control group did not receive any Transverse 
Abdominis Plane block.  
           Both groups were given 1g of paracetamol infusion every 6 hourly and 
patient controlled analgesia with fentanyl. The total requirement of fentanyl 
was observed.   
           Pain scores were analysed using Numerical Rating Scale, both at rest 
and during movement or cough. Any episodes of nausea, vomiting, sedation 
and complications due to catheter placement were also noted.   
         Median pain scores were  less in the Transverse Abdominis Plane block 
group when compared to control group from first postoperative day onwards 
with a significant difference, with P values of <0.05. Mean fentanyl use was 
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1237±145µg in control group whereas 664±134µg in Transverse Abdominis 
Plane group.   
       Thus this study concluded that Transverse Abdominis Plane block 
significantly reduced the requirement of fentanyl, and the complications 
associated with fentanyl  usage. 
 
7)Jumanam baaJ et al
15
,(Oct,2010) conducted a study regarding Ultrasound-
guided transversus abdominis plane (TAP) block for intra-operative and 
postoperative analgesia. Here they evaluated the efficacy of TAP block for 
postoperative caesarean delivery analgesia and did a randomized, double-blind, 
placebo-controlled trial was at King Khalid University Hospital on 40 patients 
undergoing caesarean delivery under spinal anaesthesia with bupivacaine and 
fentanyl. At the end of surgery the patients received bilateral ultrasound-guided 
TAP block either with bupivacaine 0.25% (B group) 20 patients, or saline (S 
group, or placebo group) 20 patients, followed by patient controlled analgesia 
with IV morphine only. Each patient was assessed 24 hours after delivery for 
pain, morphine consumption, nausea, vomiting, sedation, patient‟s satisfaction, 
and also pain relief during mobilization (24 hours postcaesarean section). 
        The  Results were Total morphine consumption was reduced more than 
60% in the bupivacaine group; the bupivacaine group also reported improved 
satisfaction with their pain relief over 24 hours after surgery, reduced morphine 
consumption, less nausea, vomiting, and better patient‟s satisfaction. 
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       Thus Ultrasound-guided TAP block improved postoperative analgesia, 
reduced morphine consumption and improved patient‟s satisfaction regarding 
analgesia after caesarean delivery. 
  
8) D. Belavy et al
9 
(Aug,2009) evaluated the analgesic efﬁcacy of the 
ultrasound (US)-guided TAP block in patients undergoing Caesarean delivery. 
        They conducted a randomized, double-blind, placebo-controlled trial at a 
tertiary maternity hospital. Fifty women undergoing Caesarean delivery 
received bilateral USG-guided TAP blocks with either ropivacaine 0.5% or 
saline. All participants received a spinal anaesthetic with bupivacaine and 
fentanyl, followed by postoperative acetaminophen, non-steroidal anti- 
inﬂammatory drugs, and patient-controlled i.v. morphine without long-acting 
intrathecal opioids. Each patient was assessed 24 h after delivery for morphine 
usage, average pain score, nausea, vomiting, pruritis, drowsiness, and 
satisfaction with pain relief. 
              The Results were Total morphine use in 24 hr was reduced in the 
active group (median 18.0 mg) compared with the placebo group (median 31.5 
mg, P,0.05). The active group reported improved satisfaction with their pain 
relief measured by visual analogue scale compared with the placebo group 
(median 96 vs 77 mm, P¼0.008) and came to conclude that USG-guided TAP 
block reduces morphine requirements after Caesarean delivery when used as a 
component of a multimodal analgesic regimen. 
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9) John G. McDonnell,et
14 
al(Jan 2008)evaluated  the analgesic efficacy of 
transverse abdominus plane block over the first 48 postoperative hours after 
cesarean delivery performed through a Pfannensteil incision, in a randomized 
controlled, double-blind, clinical trial. 
                 Fifty women undergoing elective caesarean delivery were 
randomized to undergo TAP block with ropivacaine (n  25) versus placebo (n  
25), in addition to standard postoperative analgesia comprising patient-
controlled IV morphine analgesia and regular diclofenac and acetaminophen. 
All patients received a standard spinal anaesthetic, and at the end of surgery, a 
bilateral TAP block was performed using 1.5 mg/kg ropivacaine (to a maximal 
dose of 150 mg) or saline on each side. Each patient was assessed 
postoperatively by a blinded investigator: in the post anaesthesia care unit and 
at 2, 4, 6, 12, 24, 36, and 48 hr postoperatively 
                    TAP block with Ropivacaine compared with placebo reduced 
postoperative visual analogue scale pain scores. Mean total morphine 
requirements in the first 48 postoperative hours were also reduced (6626 vs 
1814 mg, p 0.001), as was the 12-hr interval morphine consumption up to 36 hr 
postoperatively. The incidence of sedation was reduced in patients undergoing 
TAP blockade. There were no complications attributable to the TAP block. 
They concluded that TAP block, as a component of a multimodal analgesic 
regimen, provided superior analgesia when compared with placebo block up to 
48 postoperative hours after elective caesarean delivery. 
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                       MATERIALS AND METHODS   
 
              This study was conducted at the Institute of Obstetrics and 
Gynaecology, Egmore, Chennai-600008, attached to Madras Medical College 
on 75 patients undergoing lower segment caesarean section both emergency 
and elective surgeries. 
             The study was conducted after getting Institutional Ethical committee 
clearance. Informed written consent was obtained from the patients included in 
the study.   
 
Study Design : 
            This was a Prospective, Randomized, single Blinded, Placebo 
controlled Clinical study. Patients were divided into 3 groups of 25 each. Only 
patients meeting the selection criteria were included in the study.  
 
          Randomisation was done by closed cover method to  
              Group -1(Transversus Abdominis Plane block with normal saline) 
              
             Group -2(Transversus abdominis plane block with 0.25% bupivacaine) 
             
             Group -3(Transversus abdominis plane block with 0.5% ropivacaine). 
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AIMS AND OBJECTIVES:  
             To compare post operative analgesia using Ropivacaine 0.5%   and 
Bupivacaine 0.25% in bilateral transversus abdominis plane block administered 
after Lower segment caesarean section  under spinal anaesthesia . 
 
INCLUSION CRITERIA: 
  
• Age         : 20 years to 35 yrs 
• BMI        :<30kg/m2 
• Surgery  : Elective And Emergency 
• Normal liver and renal function test, coagulation profile 
• Who have given valid informed consent. 
 
 
Secondary objectives  
1. To evaluate the duration of post operative analgesic efficacy of these 
drugs. 
2. To assess post operative  haemodynamics 
3. Post operative visual analogue scale pain score. 
4. Complication rate. 
5. To evaluate postoperative iv/im analgesic initiation time 
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EXCLUSION CRITERIA: 
 Not satisfying inclusion criteria. 
 Lack of written informed consent 
 Allergy to drugs used. 
 Patient refusal. 
 Abnormal liver function test 
 Patients with severe cardiovascular ,respiratory, renal, hepatic diseases 
 Infection at injection site 
 Clotting abnormalities 
Materials: 
• 18G venflon 
• 25G /23G Quinckes spinal needle, short bevel needle 
• Ultrasound machine 
• Drugs–inj Ropivacaine0.5%,inj bupivacaine0.25%,inj hyperbaric 
bupivacaine0.5%, inj.tramadol, emergency drugs and normal 
saline 
• Monitors – ECG, NIBP, SPO2, ECG. 
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OUTCOMES MEASURED: 
Primary outcome:  
          The duration of post operative analgesia  of these drugs. 
Secondary outcomes: 
1. Post operative  haemodynamics 
2. Post operative visual analogue scale pain score. 
3. Complication rate. 
4. Postoperative iv/im analgesic initiation time 
 
 
 
ASSESSMENT OF PAIN USING VISUAL ANALOGUE SCORE
5,18
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   STUDY METHOD:  
           All patients were assessed in our pre-anaesthetic clinic. Patients with 
exclusion criteria were  excluded. After getting informed consent, patients who 
satisfied our inclusion criteria were taken under our study.  
      Patients were divided into 3 groups of 25 each. Randomisation was done 
and patients were divided  to 3 groups as Group 1,Group 2,Group 3 
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Group 1:Bilateral Transversus  Abdominis Plane  block with Normal saline 
 Group 2: Bilateral Transversus Abdominis Plane block wth 0.25% 
Bupivacaine. 
Group 3:Bilateral Transversus Abdominis Plane block with 0.5% Ropivacaine.  
           Inside the operation theatre, all basic monitors were connected (ECG, 
NIBP, SpO2, temperature monitoring). All basal parameters were noted.  
          Patient was given subarachnoid block under sterile aseptic precautions 
with 2ml of 0.5% HYPERBARIC BUPIVACAINE and after attaining a block 
height of T6, surgery proceeded and  monitored intraoperatively.  
          At the end of surgery, Transversus abdominis plane block was given 
bilaterally under ultrasound guidance with either saline,bupivacaine or 
ropivacaine. 
 
PROCEDURE:  
              Patient in supine position, ultrasound probe placed transverse to the 
abdominal wall between lower costal margin and iliac crest. 
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        Transverse abdominis plane was identified after visualising external 
oblique aponeurosis,internal oblique aponeurosis and transversus abdominis 
muscle and reached using 18G needle with bevel facing superiorly . 
         Correct placement of needle tip confirmed by injecting 2-3ml Bolus dose 
which cause hydrodissection and  20 ml of the test drug was administered. 
Procedure repeated on the opposite side.  
         Post operatively patients were monitored in Postoperative ward. Various 
parameters like HR, Blood pressure (both systolic and diastolic), SPO2, Visual 
Analogue Scale (VAS) were observed for 48 hours post operatively. Incidences 
of side effects were also noted  and the time for analgesic initiation was noted. 
 
 
STATISTICAL ANALYSIS:  
Data was analysed using SPSS (Statistical Package for Social Sciences)  for 
windows version 22. Mean heart rates, systolic BP, Diastolic BP, Mean arterial 
BP,VAS scores between the three groups were compared using ANOVA 
(analysis of variances) p value of <0.05 was taken as statistically significant. 
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                          OBSERVATION AND ANALYSIS 
 
 
DEMOGRAPHIC  DATA:  
 The three groups were compared with respect to their age, weight, and ASA 
status 
 
  
Table 1. Patient Characteristics 
 
 
The mean age of the patients in the control group was 25.6(±2.9)yrs. In the 
Bupivacaine treatment group was 26.84(±4.1) yrs and the Ropivacaine group 
was 24.9(±3.8) 
  
Variable Group 1 (Normal Saline)  Group 2                               
(0.25% Bupivacaine) 
Group 3                               
(0.5% 
Ropivacaine)  
Age (Years) 25.6(±2.9) 26.84(±4.1) 24.9(±3.8) 
Weight (Kg) 67.28(±9.61) 70.16(±9.80) 67.8(±10.30) 
Height (cm) 154.08(±6.66) 156.24(±7.72) 154.84(±4.40) 
LSCS       
Elective 8(32%) 11(44%) 11(44%) 
Emergency 17(68%) 14(56%) 14(56%) 
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The mean weight of the patients in the control group was 67.28(±9.61)kg. In 
the Bupivacaine treatment group was 70.16(±9.80)kg and in the Ropivacaine 
group was 67.8(±10.30)kg 
 
The mean height of the patients in the control group was 154.08(±6.66)cm. In 
the Bupivacaine treatment group was 156.24(±7.72)cm .And in the 
Ropivacaine group was 154.84(±4.40)cm. 
 
 
 
Figure 1. Mean age of the Intervention groups 
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                    Figure 2. Mean weight of the Intervention groups 
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             Figure 3. Mean Height of the Intervention groups 
 
 
 
In the placebo group, 8(32%) underwent elective LSCS, 17(68%) underwent 
emergency LSCS. 
In the Bupivacaine group, 11(44%) underwent Elective LSCS, 14(56% 
underwent emergency LSCS) 
In the Ropivacaine group, 11(44%) underwent Elective LSCS, 14(56% 
underwent emergency LSCS)  
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Figure 4. Type of Surgery in Intervention groups 
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Table 2.Indications for surgery 
 
 
Indications Group 1 (Normal 
Saline)  
Group 2                               
(0.25% 
Bupivacaine) 
Group 3                               
(0.5% 
Ropivacaine)  
Mobile head 1(4%) 0(0%) 0(0%) 
Failed induction 2(8%) 1(4%) 2(8%) 
Fetal distress 1(4%) 2(8%) 4(16%) 
Oligohydramnios 2(8%) 0(0%) 2(8%) 
PIH 1(4%) 0(0%) 2(8%) 
Post dated 1(4%) 0(0%) 0(0%) 
Previous LSCS 10(40%) 15(60%) 10(40%) 
CPD 7(28%) 2(8%) 4(16%) 
Breech 0(0%) 3(12%) 0(0%) 
Twins 0(0%) 2(8%) 1(4%) 
 
 
 
 
 
 
 
 
52 
Table 3. Mean duration of analgesia (in hours) 
 
   Mean duration 
of analgesia in 
Hours 
Range 95% C.I F Statistic p 
value 
Group 1 
(Normal 
Saline)  
1.49±0.54 0.5-2.5 1.2-1.7 
141.096 <0.01* 
Group 2                               
(0.25% 
Bupivacaine) 
6.22±1.19  4- 8 5.72-6.71 
Group 3                              
(0.5% 
Ropivacaine)  
20.6±7.13 7 – 31 17.65-23.54 
 
The mean duration of analgesia in the control group was 1.49 hours, ranging 
from 0.5 to 0.25 hours. 
 
The mean duration of analgesia in the intervention group who received 0.25% 
Bupivacaine was 6.22 hours, ranging from 4 to 8 hours. 
 
The mean duration of analgesia in the group which received 0.5% Ropivacaine 
was 20.6 hours, ranging between 17.65 to 23.54 hours. 
 
The mean duration of analgesia was compared between different intervention 
groups using ANOVA, the difference was found to be statistically significant. 
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Figure 5. Mean Duration of Analgesia (in hours) in the Intervention groups 
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             The above Figure shows that the mean duration of  analgesia is more in 
Ropivacaine Group when compared to Bupivacaine Group and Saline Group. 
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Table 4. Mean Pain scores between intervention groups 
 
Time duration Intervention groups 
Group 1 (Normal 
Saline)  
Group 2                               
(0.25% 
Bupivacaine) 
Group 3                              
(0.5% 
Ropivacaine)  
15 min 0.96 0 0 
30 min 2.2 0.2 0.04 
1 hour 4.28 0.72 0.36 
2 hours 6.16 1.52 0.84 
4 hours 7 3 1.6 
6 hours   4.18 2.64 
12 hours   5.73 4.44 
24 hours     5.68 
36 hours     6.14 
48 hours     7 
 
 
 In comparing  mean pain scores using VAS across intervention groups, Group 
3 which received Ropivacaine, reached the threshold VAS for analgesic 
injection after 36 hours. In the Bupivacaine group, it was 12 hours, while in the 
Control group it was just 2-4 hours. 
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Comparision of Mean VAS Scores between the three groups. 
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Table 5. Comparing mean VAS scores between intervention groups using 
ANOVA 
 
 F Statistic p value 
VAS 15 min 61.714 <0.01* 
VAS 30 min 60.693 <0.01* 
VAS 1 hour 141.225 <0.01* 
VAS 2 hours 438.226 <0.01* 
VAS 4 hours 30.389 <0.01* 
VAS 6 hours 14.06 <0.01* 
VAS 12 hours 12.138 <0.01* 
 
 
* - statistically significant 
  The mean pain scores as measured using Visual Analogue scale was 
compared across intervention groups, at 15 min, 30 min, 1 hour, 2 hours, 4 
 
58 
hours, 6 hours, and 12 hours. The difference was found to be statistically 
significant at each instance.  
 
Table 6. Mean Heart rate of intervention groups 
 
Mean Heart rate 
Intervention groups 
Group 1 
(Normal 
Saline)  
Group 2                               
(0.25% 
Bupivacaine) 
Group 3                               
(0.5% 
Ropivacaine)  
15 min 84.76 83.36 82.24 
30 min 88.76 83.44 83.48 
1 hour 94.56 84.44 82.88 
2 hours 96.5 87.36 85.32 
4 hours 91.5 91.6 89.16 
6 hours   97.23 93.4 
12 hours   98.45 96.96 
24 hours     100.45 
36 hours     105.75 
48 hours     121 
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Table 7. Comparing mean HR between intervention groups using ANOVA 
  
Heart rate F Statistic p value 
Heart rate 15 min 0.412 0.664 
Heart rate 30 min 2.512 0.088 
Heart rate 1 hour 12.122 
<0.01* 
Heart rate 2 hours 11.178 
<0.01* 
Heart rate 4 hours 0.811 0.45 
Heart rate 6 hours 2.71 0.107 
Heart rate 12 hours 0.289 0.595 
 
There was no significant variation overall in the Mean Heart rate across the 
three intervention groups.  
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Table 8. Mean Systolic BP of intervention groups 
 
Mean systolic 
BP 
Intervention groups 
Group 1 
(Normal Saline)  
Group 2                               
(0.25% Bupivacaine) 
Group 3                               
(0.5% Ropivacaine)  
15 min 122.44 121.56 118.44 
30 min 126.88 121.56 120.68 
1 hour 133.24 122.6 123.72 
2 hours 135 130.36 126.4 
4 hours 137 134.16 129 
6 hours   138.14 131.32 
12 hours     134.16 
24 hours     136.47 
36 hours     138.43 
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Table 9. Mean Diastolic BP of intervention groups 
 
Mean diastolic 
BP 
Intervention groups 
Group 1 
(Normal 
Saline)  
Group 2                              
(0.25% Bupivacaine) 
Group 3                               
(0.5% Ropivacaine)  
15 min 75.44 74.84 75.8 
30 min 81.36 76.76 77.6 
1 hour 86.24 78.83 79.72 
2 hours 86.82 83.88 83.48 
4 hours 91.5 87.32 85.6 
6 hours   91.73 87.96 
12 hours   92 89.92 
24 hours     92.06 
36 hours     93.71 
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Table 10. Mean arterial pressure between intervention groups 
 
Mean arterial 
Pressure 
Intervention groups 
Group 1 
(Normal Saline)  
Group 2                               
(0.25% Bupivacaine) 
Group 3                              
(0.5% Ropivacaine)  
15 min 91.1 90.4 90.01 
30 min 96.5 91.69 91.96 
1 hour 101.9 94.01 94.38 
2 hours 102.88 99.37 97.78 
4 hours 106.66 102.93 100.06 
6 hours   107.91 102.4 
12 hours     104.66 
24 hours     106.8 
36 hours     108.6 
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Table 11.  Comparing mean HR between 0.5% Ropivacaine & 0.25% 
Bupivacaine 
 
 
 
           The mean heart rate at 1 hour for the group which received 0.5% 
Ropivacaine was 82.88, and for 0.25% Bupivacaine group was 84.44. The 
mean difference was -1.56 with a 95% Confidence interval ranging from -5.63 
to 2.61. The difference was not statistically significant. 
           The mean heart rate at 2 hours for the group which received 0.5% 
Ropivacaine was 85.32, and for 0.25% Bupivacaine group was 87.36. The 
mean difference was -2.04 with a 95% Confidence interval ranging from -5.981 
to 1.901. The difference was not statistically significant. 
         Hence in terms of hemodynamic stability, 0.5% Ropivacaine and 0.25% 
Bupivacaine do not differ significantly from each other. 
Variable 
Intervention  
groups 
Mean SD 
Std. 
Error Mean 
Mean  
diff. 
Std. 
Error 
Diff. 
p value 
95% C.I 
Upper  
bound 
Lower  
bound 
HR 1hour 0.5 %  
Ropivacaine 
82.88 7.299 1.46 -1.56 2.024 0.445 -5.63 2.51 
0.25%  
bupivacaine 
84.44 7.012 1.402 
HR 2 hours 0.5 %  
Ropivacaine 
85.32 6.731 1.346 -2.04 1.96 0.303 -5.981 1.901 
0.25%  
Bupivacaine 
87.36 7.123 1.425 
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Table 12. Comparing hemodynamics between 0.5% Ropivacaine  &  
0.25% Bupivacaine 
 
Variable 
Intervention  
groups 
Mean S.D 
Std. 
Error         
Mean 
Mean 
diff 
Std. 
Error      
Diff 
P 
value 
95% C.I 
Upper 
bound 
Lower  
bound 
Sys BP 
30 min 
Ropivacaine  
0.5% 
120.68 10.758 2.152 -0.88 2.616 0.738 -6.14 4.38 
Bupivacaine 
0.25% 
121.56 7.439 1.488 
Sys  BP 
1 hour 
Ropivacaine 
0.5% 
123.72 10.718 2.144 1.12 3.159 0.724 -5.231 7.471 
Bupivacaine 
0.25% 
122.6 11.601 2.32 
Sys BP 
2  hours 
Ropivacaine 
0.5% 
126.4 9.12 1.824 -3.96 2.427 0.109 -8.84 0.92 
Bupivacaine 
0.25% 
130.36 8.005 1.601 
Sys BP  
6 hours 
Ropivacaine 
0.5% 
131.32 9.15 1.83 -6.816 2.485 <0.01* -11.822 -1.811 
Bupivacaine 
0.25% 
138.14 7.692 1.64 
Dia BP 
1 hour 
Ropivacaine 
0.5% 
79.72 6.828 1.366 0.887 1.674 0.599 -2.481 4.254 
Bupivacaine 
0.25% 
78.83 4.631 0.945 
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The mean systolic BP (30 min) in Ropivacaine group was 120.68 and 
Bupivacaine group was 123.72. The mean difference was -0.88 with 95% C.I -
6.14 to 4.38. The difference was not statistically significant.  
 
The mean systolic BP (1 hr) in Ropivacaine group was 123.72 and Bupivacaine 
group was 122.6. The mean difference was 1.12 with 95% C.I -5.231 to 7.471. 
The difference was not statistically significant.  
  
The mean systolic BP (2 hrs) in Ropivacaine group was 126.4 and Bupivacaine 
group was 130.36. The mean difference was -3.96 with 95% C.I -8.84 to 0.92. 
The difference was not statistically significant.  
 
The mean systolic BP (6 hrs) in Ropivacaine group was 131.32 and 
Bupivacaine group was 138.14. The mean difference was -6.816 with 95% C.I 
-11.822 to -1.811 The difference was statistically significant. Systolic BP in the 
Ropivacaine group was significantly lower than the Bupivacaine group at 6 
hours. 
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The mean diastolic BP (1 hr) in Ropivacaine group was 79.72 and Bupivacaine 
group was 78.83. The mean difference was 0.887 with 95% C.I.-2.481 to 4.254. 
The difference was not statistically significant.  
Table 16. Comparing MAP between 0.5% Ropivacaine & 0.25% 
Bupivacaine 
 
 
 
 
Variable 
Intervention  
groups 
Mean SD 
Std. 
Error 
Mean 
Mean 
diff 
Std. 
Error 
diff 
p value 
95% C.I 
Upper  
bound 
Lower  
bound 
MAP   
30 min 
0.5 %  
Ropivacaine 
91.96 8.16061 1.63212 0.26667 1.94976 0.892 -3.65359 4.18693 
0.25%  
Bupivacaine 
91.6933 5.33326 1.06665 
MAP   
1 hour 
0.5 %  
Ropivacaine 
94.3867 7.60524 1.52105 0.37278 1.86503 0.842 -3.37917 4.12473 
0.25%  
Bupivacaine 
94.0139 5.16536 1.05437 
MAP  
2 hours 
0.5 %  
Ropivacaine 
97.7867 6.86435 1.37287 -1.58667 1.74517 0.368 -5.09557 1.92224 
0.25%  
Bupivacaine 
99.3733 5.38716 1.07743 
MAP   
6 hours 
0.5 %  
Ropivacaine 
102.4133 6.0425 1.2085 -4.78364 1.61478 <0.01* -8.03596 -1.53131 
0.25%  
Bupivacaine 
107.197 4.86393 1.03699 
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The Mean Arterial Pressure in the Ropivacaine group at 30 min was 91.96 and 
Bupivacaine group was 91.69. The mean difference was 0.26 with 95% C.I -
3.65 to 4.18. The difference was not statistically significant.  
 
The Mean Arterial Pressure in the Ropivacaine group at 1 hr was 94.38 and 
Bupivacaine group was 94.01. The mean difference was 0.37 with 95% C.I -
3.3797 to 4.124. The difference was not statistically significant.  
 
The Mean Arterial Pressure in the Ropivacaine group at 2 hr was 97.78 and 
Bupivacaine group was 99.37. The mean difference was -1.58 with 95% C.I -
5.09 to 1.92. The difference was not statistically significant.  
 
The Mean Arterial Pressure in the Ropivacaine group at 6 hr was 102.41and 
Bupivacaine group was 107.197. The mean difference was -4.78 with 95% C.I 
-8.035to 1.53. The difference was statistically significant. Mean arterial 
pressure was significantly lower in the Ropivacaine group than Bupivacaine 
group. 
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                                 DISCUSSION   
 
            Transversus Abdominis Plane Block has a major role in abdominal 
surgeries as an analgesic regimen but it is not fully defined. In our study we 
demonstrate  its probable efficacy in patients undergoing lower segment 
caesarean section in terms of reducing pain scores and opioid usage for the first 
48 hours. We did transversus abdominis plane block under ultrasound 
guidance. 
In our study, the demographic profile was comparable with respect to 
mean age, body weight and ASA physical status. We did bilateral Transversus 
Abdominis Plane block in the group A with normal saline, group B with 0.25% 
bupivacaine and group C with 0.5% ropivacaine .They received 20 ml of the 
respective drug on each side. In many studies Epidural Ropivacaine was found 
to be significantly less potent than Bupivacaine by a factor of 0.4. Ropivacaine 
was 60% as potent as Bupivacaine when used for epidural pain relief in labour. 
The analgesic potency of Ropivacaine was 0.6 relative to Bupivacaine.So we 
used 20 ml of either 0.25 % Bupivacaine or 0.5 % Ropivacaine compared with 
saline as the drugs under study for use in TAP block considering Ropivacaine 
to be approximately half as potent as Bupivacaine.  In the postoperative ward  
the pain scores were monitored and the time of initiation of analgesia with 
opioid were observed. And the hemodynamic parameters like Heart rate, 
systolic BP, diastolic BP and Mean arterial BP were measured.  
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        The results showed that there is no significant difference in the heart rate, 
blood pressure in the two groups of women who received 0.25% Bupivcaine  
and 0.5%  Ropivacaine. 
      This is correlating with the following studies: 
 
     1)Neha Fuladi et al
23
, did a comparative study of bupivacaine 0.25% versus 
ropivacaine 0.5% in transversus abdominis plane block for postoperative 
analgesia in lower abdominal surgeries. 
They evaluated the efficacy of unilateral TAPB with bupivacaine and 
ropivacaine for postoperative analgesia in lower abdominal surgeries like 
hernia repair, appendicectomy in a hospital based, single blind, and 
prospective, randomized controlled clinical trial. Each patient was assessed 
postoperatively by a blinded investigator in post-anaesthesia care unit every 5 
minutes for half an hour, then every 15 minutes till 2 hours and at 4, 6, 12, 24, 
48 hours postoperatively in ward. The results were Mean duration of analgesia 
was 420.6 minutes with SD of +14.01 in Bupivacaine group and 2187 minutes 
with SD of +1011.09 in Ropivacaine group which was found to be statistically 
significant.But the hemodynamic parameters remained the same. Hence they 
concluded 0.5% ropivacaine provided longer duration of analgesia than 0.25 % 
bupivacaine when used in TAPB on patients of lower abdominal surgeries. 
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2)Himat Vaghadia et al
12
, did a multicentre trial of ropivacaine 7.5 
mg.m1-1vs bupivacaine 5 mg.m1-1for supraclavicular brachial plexus 
anesthesia and compared the efficacy of ropivacaine 7.5 mg/ml with 
bupivacaine 5.0 mg/ml  for subclavian perivascular brachial plexus block. 
  Onset times and duration of sensory and motor block were similar 
between groups. Hemodynamic parameters like heart rate and blood pressure 
were similar. Quality of muscle relaxation judged as excellent by the 
investigators was not significantly different (ropivacaine - 35/49, bupivacaine 
- 30/49). The median time to first request for analgesia was comparable 
between the two groups (I I- 12 hr).  
 
         The VAS scores were significantally low in Group 3 and Group 2 ,in 
which 0.5%  Ropivacaine and 0.25% Bupivacaine were used respectively. This 
is correlating with the studies as follows: 
 
1) Kawahara R, et al21 conducted a randomised control trial to study the 
analgesic efficacy of ultrasound-guided transversus abdominis plane block with 
midaxillary approach after gynaecologic laparoscopic surgery. 
                 Adult patients (n = 119) undergoing laparoscopic gynaecologic 
surgery were randomized to undergo either TAP block with ropivacaine (Group 
A, n = 60) or that with saline (Group B, n = 59), in a blinded manner. The 
analgesic effect was postoperatively evaluated using a four-grade pain score 
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and the prince Henry pain scale (PHS) at 0, 6, 12, and 24 h. Postoperative 
tramadol PCA consumption and vomiting/nausea were recorded.  
     They concluded that Postoperative pain/nausea and PCA consumption were 
significantly lower in patients with TAP block in the early postoperative 
stage. TAP block with a mid-axillary approach holds considerable promise as a 
part of a balanced postoperative analgesic regimen following laparoscopic 
gynaecologic surgery. 
2)  Loadsman JA et al
25
 ,did a retrospective review regarding the role of 
transversus abdominis plane blocks in women undergoing total laparoscopic 
hysterectomy. 
           Women with a TAP block had a significantly shorter length of stay 
,lower total perioperative and postoperative opioid use when compared with 
those without a TAP block. There were no complications related to a TAP 
block. 
 
3) McDonnell, et al
14
 studied the Analgesic Efficacy of Transversus 
Abdominis Plane Block After Caesarean Delivery over the first 48 
postoperative hours , in a randomized controlled, double-blind, clinical trial and 
concluded that The TAP block, as a component of a multimodal analgesic 
regimen, provided superior analgesia when compared with placebo block up to 
48 postoperative hours after elective caesarean delivery. 
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4) Patel SA, et al
24
 evaluated the role of  Transversus abdominis 
plane block for postoperative analgesia after caesarean delivery. They 
compared the  postoperative adjunctive oral narcotic use in women who 
underwent caesarean delivery and received the TAP block vs those who 
received neuraxial narcotics. After adjusting for confounders and the presence 
of antecedent labor, there remained a significant reduction in the total oral 
narcotic doses given to women who underwent a TAP block compared to other 
forms of analgesia. The TAP block is thus associated with decreased oral 
narcotic usage 24-48 h following caesarean delivery. 
 
5) Abdallah et al
10
, conducted a study regarding the analgesic utility of 
transversus abdominis plane (TAP) block after Caesarean delivery. This 
systematic review and meta-analysis examines whether TAP block can reduce 
i.v. morphine consumption in the ﬁrst 24 hr after CD. The authors retrieved 
randomized controlled trials comparing TAP block with placebo in CD. 
Postoperative i.v. morphine consumption during the ﬁrst 24 hr was selected as 
a primary outcome. Pain scores and both maternal and neonatal opioid-related 
side-effects were secondary outcomes            
          They found that TAP block provides superior analgesia compared with 
placebo and can reduce the ﬁrst 24 hr morphine consumption in the setting of a 
multimodal analgesic regimen that excludes spinal morphine. TAP block can 
provide effective analgesia when spinal morphine is contraindicated or not 
used. 
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6) ) D. Belavy et al
9 evaluated the analgesic efﬁcacy of the ultrasound (US)-
guided TAP block in patients under- going Caesarean delivery. 
        They conducted a randomized, double-blind, placebo-controlled trial at a 
tertiary maternity hospital. Fifty women undergoing Caesarean delivery 
received bilateral US-guided TAP blocks with either ropivacaine 0.5% or 
saline.. Each patient was assessed 24 h after delivery for morphine usage, 
average pain score, nausea, vomiting, pruritis, drowsiness, and satisfaction with 
pain relief. 
              The Results were Total morphine use in 24 h was reduced in the active 
group (median 18.0 mg) compared with the placebo group (median 31.5 mg, 
P,0.05). The active group reported improved satisfaction with their pain relief 
measured by visual analogue scale compared with the placebo group (median 
96 vs 77 mm, P¼0.008) and came to conclude that US-guided TAP block 
reduces morphine requirements after Caesarean delivery when used as a 
component of a multimodal analgesic regimen. 
 
7) Uma Srivastava,et al
36
 conducted a double-blind, randomized trial to 
evaluate the  Efficacy of transversus abdominis plane block for post caesarean 
delivery analgesia.  
          62 parturients undergoing caesarean section were randomized in a 
double-blind manner to receive either bilateral TAP block at the end of surgery 
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with 20 ml of 0.25% bupivacaine or no TAP block, in addition to standard 
analgesic  and intravenous patient-controlled analgesia (PCA) tramadol. 
                Each patient was assessed after surgery by an independent observer 
for pain at rest and on movement using numeric rating scale of 0-10, time of 1st 
demand for tramadol, total consumption of PCA tramadol, satisfaction with 
pain management and side effects for a period of 24 hours. 
                 The results were Use of tramadol was reduced in patients given TAP 
block by 50% compared to patients given no block during 48 h after 
surgery.Pain scores were lower both on rest and activity at each time point for 
24 hr in study group,time of first analgesia was significantly longer, satisfaction 
was higher, and side effects were less in study group compared to control 
group.  
                The mean analgesic duration and the time for requirement of opioid 
was significantly increased in Group 3 (0.5%Ropivacaine) and Group 2(0.25% 
Bupivacaine) when compared to Group 1(Normal saline). Also 0.5% 
Ropivacaine produces longer duration of analgesia than 0.25% Bupivacaine. 
This is consistent with the following studies: 
 
1)Shradha sinha et al
32
,  did a Comparison of ultrasound-guided transversus 
abdominis plane block with bupivacaine and ropivacaine as adjuncts for 
postoperative analgesia in laparoscopic cholecystectomies .   
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         He investigated whether ropivacaine with its inherent advantages 
(anaesthetic potency, long duration of action, favourable toxicity profile) is 
superior to bupivacaine for providing post-operative analgesia when used for 
TAP block in patients undergoing laparoscopic cholecystectomy and found that 
the ultrasound-guided deposition of ropivacaine 0.375% in the TAP provided 
superior analgesia in the early post-operative period in comparison to 
bupivacaine 0.25%.  
 
2) Neha Fuladi et al
23
, did a comparative study of bupivacaine 0.25% versus 
ropivacaine 0.5% in transversus abdominis plane block for postoperative 
analgesia in lower abdominal surgeries. 
        They evaluated the efficacy of unilateral TAPB with bupivacaine and 
ropivacaine for postoperative analgesia in lower abdominal surgeries like 
hernia repair, appendicectomy in a hospital based, single blind, and 
prospective, randomized controlled clinical trial. Each patient was assessed 
postoperatively by a blinded investigator in post-anesthesia care unit every 5 
minutes for half an hour, then every 15 minutes till 2 hours and at 4, 6, 12, 24, 
48 hours postoperatively in ward. The results were Mean duration of analgesia 
was 420.6 minutes with SD of +14.01 in Bupivacaine group and 2187 minutes 
with SD of +1011.09 in Ropivacaine group which was found to be statistically 
significant.But the hemodynamic parameters remained the same. Hence they 
concluded 0.5% ropivacaine provided longer duration of analgesia than 0.25 % 
 
76 
bupivacaine when used in TAPB on patients of lower abdominal surgeries. 
There were no complications attributable to TAPB or drugs under study. 
                No significant complications were observed during our study except 
a few of incorrect plane of drug deposition and they were excluded from the 
study. 
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SUMMARY 
 
                   Women having a Caesarean delivery present a unique set of 
challenges to the anaesthesiologist after operation. These motivated women 
want to be alert, comfortable and mobile in order to care for their baby. As part 
of a multimodal analgesic regimen, opioids are required initially to achieve 
effective analgesia. However, opioids are associated with dose-dependent side-
effects including nausea, vomiting, pruritus, sedation, and respiratory 
depression. Techniques that reduce opioid requirements may be of benefit in 
this population. 
                 The Transversus abdominis plane (TAP) block reduces morphine use 
after abdominal surgery, including Caesarean delivery. The block has opioid-
sparing effects, reduces antiemetic use, and improves satisfaction with pain 
relief. There are no major neurovascular structures near the area of block which 
is of great advantage to perform this block. 
                However, there is a small proportion of patients in whom neuraxial 
techniques are contraindicated or not possible due to coagulation abnormalities 
and other issues like sympathetic blockade after epidural anaesthesia.These 
patients may be benefited by Transversus abdominis plane block. 
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               The complications of TAP block which are very rare like 
Intraperitoneal injection, Bowel injury, Hepatic injury can be avoided with the 
use of ultrasound guidance while giving the block.Thus transversus abdominis 
plane block is a superior and less harmful mode of postoperative analgesia to 
the patients undergoing lower abdominal surgeries like caesarean section. 
In this block ropivacaine with its inherent advantages (anaesthetic potency, 
long duration of action, favourable toxicity profile) is superior to bupivacaine 
for providing post-operative analgesia. 
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CONCLUSION 
             In conclusion, our study showed that ultrasound-guided TAP blocks in 
the manner we have described resulted in reduced systemic opioid consumption 
and a positive impact on maternal satisfaction in women undergoing caesarean 
section. We propose that the TAP block is another arsenal in the obstetric 
anaesthesiologist‟s armamentarium in managing pain after caesarean section , 
or in those with contraindications to long-acting neuraxial opioids. 
            Also we conclude that 0.5% Ropivacaine provided longer duration of 
analgesia than 0.25% Bupivacaine when used in TAPB for providing 
postoperative analgesia after lower abdominal surgeries. It has an excellent 
safety profile to date. It shows outstanding clinical utility in terms of reliability 
& effective analgesia. 
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                            INFORMATION TO PARTICIPANTS 
 
Investigator                      :       Dr.  NITHYA.G  
Name of the Participant: 
Title.  “Bilateral transverse abdominus plane block using Ropivacaine  & 
Bupivacaine for Lower Segment Caesarean Section under Spinal 
Anaesthesia”. 
(A Prospective, randomized, double blinded , placebo controlled study for 
evaluating the analgesic efficacy of (0.5%)Ropivacaine Vs(0.25%) 
Bupivacaine  ) 
 
You are invited to take part in this research study. We have got approval from 
the IEC. You are asked to participate because you satisfy the eligibility criteria. 
We want to compare and study the safety and  post operative analgesic efficacy 
of  ropivacaine(0.5%)and bupivacaine (0.25%) in bilateral transverse 
abdominis plane  block after spinal anaesthesia for lower segment caesarean 
section . 
What is the Purpose of the Research: 
For lower segment caesarean section, transverse abdominis plane block 
performed using ultrasound after spinal anaesthesia to study 
14 
 
1. To evaluate the duration of post operative analgesic efficacy of these 
drugs. 
2. To assess Intraoperative and post operative  haemodynamics 
3. Post operative visual analogue scale pain score. 
4. Complication rate. 
5. To evaluate post operative IV/IM analgesic initiation time 
 
The Study Design: 
                           All the patients in the study will be divided into three groups. 
Group1- post operative bilateral transverse abdominis plane block performed 
using ultrasound after spinal anaesthesia using normal saline 
Group 2- post operative bilateral transverse abdominis plane block performed 
using ultrasound after spinal anaesthesia using bupivacaine (0.25%). 
 Group 3- post operative bilateral transverse abdominis plane block performed 
using ultrasound after spinal anaesthesia using ropivacaine (0.5%) . 
 
Benefits 
Transversus abdominis plane  block improves post operative hemodynamic, 
reduces opioid requirement, causes post operative pain relief. 
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Discomforts and risks 
                      Intravascular local anaesthetic injection 
                      Damage to neuro vascular structure 
  
 This intervention has been shown to be well tolerated as shown by previous 
studies. And if you do not want to participate you will have alternative of 
setting the standard treatment and your safety is our prime concern. 
Confidentiality of data and details of study and patient details concerned with 
this research will be strictly maintained. 
Time : 
Date : 
Place : 
 
Signature / Thumb Impression of Patient 
Patient Name: 
 
Signature of the Investigator : ____________________________ 
Name of the Investigator : ____________________________ 
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                                    PATIENT CONSENT FORM 
 
Study title      “Bilateral transversus abdominis plane block using 
Ropivacaine  & Bupivacaine for Lower Segment Caesarean Section under 
Spinal Anaesthesia”.   
(A Prospective, randomized, single blinded , placebo controlled study for 
evaluating the analgesic efficacy of (0.5%)Ropivacaine Vs(0.25%) 
bupivacaine) 
 
Study center:       DEPARTMENT OF ANAESTHESIOLOGY, 
                            INSTITUTE OF OBSTETRICS AND GYNAECOLOGY, 
                             RAJIV GANDHI GOVT. GENERAL HOSPITAL,  
                             MADRAS MEDICAL COLLEGE, 
                              CHENNAI-08. 
Participant name:                                                Age:                         Sex:                                
I.P.No: 
 
            I confirm that I have understood the purpose of procedure for the above 
study. I have the opportunity to ask the question and all my questions and 
doubts have been answered to my satisfaction. 
            I have been explained about the pitfall in the procedure.  I have been 
explained about the safety, advantage and disadvantage of the technique. 
17 
 
 
      I understand that my participation in the study is voluntary and that I am 
free to withdraw at anytime without giving any reason. 
 
     I understand that investigator, regulatory authorities and the ethics 
committee will not need my permission to look at my health records both in 
respect to current study and any further research that may be conducted in 
relation to it, even if I withdraw from the study. I understand that my identity 
will not be revealed in any information released to third parties or published, 
unless as required under the law. I agree not to restrict the use of any data or 
results that arise from the study. 
 
Time:          
 
Date:                                                                                             
Signature/thumb impression of patient  
 
Place:                                                                                            Patient name: 
 
Signature of the investigator: 
 
Name of the investigator: 
 
 
18 
 
COMPARISION OF THE ANALGESIC EFFICACY OF  
0.5%ROPIVACAINE AND 0.25%  BUPIVACAINE IN BILATERAL 
TRANSVERSUS ABDOMINIS PLANE BLOCK AFTER LSCS 
                                              PROFORMA 
DATE:                                     ROLL NO:                   
   
NAME:   
AGE:                         SEX:                     IP NO: 
DIAGNOSIS: 
SURGICAL PROCEDURE : 
Ht:                                                                       CVS:                              
       HB: 
Wt:                                                                       RS:                                           
BT:                      CT: 
AIRWAY:MMS -                                                         IID      -                                         
DENTITION -    
Examination of spine:                
 ASA: 
PRE OP ASSESSMENT: 
HISTORY:    Any Co-morbid illness 
                     H/O Documented Difficult Airway 
                      H/O previous surgeries/treatment 
                      H/O Difficult spinal anaesthesia 
                      H/O Drug allergy 
MEASURES OF STUDY OUTCOME: 
 B/L Transverse abdominis plane block :   Drugs   
COMPLICATIONS IN POST OPERATIVE PERIOD:  
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Hemodynamics: intra operative 
 
  
 
Events Time Systolic  
BP 
(mmHg) 
Diastolic 
BP 
(mmHg) 
MAP Heart rate 
Beats/min 
SPO2 
Baseline       
 
Immediately 
after spinal 
anaesthesia 
      
  5 mins        
 10 mins       
 15 mins       
 20 mins       
End of 
surgery 
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POST OPERATIVE ANALGESIC INITIATION TIME: 
 
 
 
  
TIME 
0 
Min 
05 
Min 
10 
min 
 
15 
Min 
20 
min 
25 
min 
30 
min 
45 
min 
60 
min 
75 
min 
90 
min 
2 
hrs 
4 
hrs 
6 
hrs 
12 
hrs 
24 
hrs 
48 
hrs 
VAS                  
HR                  
SBP                  
DBP                  
MAP                  
Rescue 
analgesia 
    
 
 
             
MuhŒ¢á x¥òjš got« 
Muha¢áÆ‹ jiy¥ò 
ánrÇa‹ mWit á»¢ir¡F¥ã‹ tÈÆšyhkš ïU¥gj‰F ouh‹°bt®° 
m¥lhÄd° ãns‹ ãsh¡ _y« òãbtbfŒ‹ mšyJ nuhãbtbfŒ‹ kUªâid 
x¥ãLjš 
MŒî Ãiya« : FHªijfŸ k‰W« kf¥ngW kU¤Jtkid, 
br‹id kU¤Jt¡ fšÿÇ, vG«ó®, br‹id.
     
g§F bgWtÇ‹ bga® :       
g§FbgWgtÇ‹ v© : 
g§FbgWgt® ïjid () F¿¡fî« 
nkny F¿¥ã£LŸs kU¤Jt MŒÉ‹ Étu§fŸ vd¡F 
És¡f¥g£lJ. v‹Dila rªnjf§fis nf£fî«, mj‰fhd jFªj 
És¡f§fis bgwî« thŒ¥gË¡f¥g£lJ. 
eh‹ ï›thŒÉš j‹Å¢irahfjh‹ g§nf‰»nw‹. vªj 
fhuz¤âdhnyh vªj f£l¤âY« vªj r£l á¡fY¡F« c£glhkš eh‹ 
ï›thŒÉš ïUªJ Éy» bfhŸsyh« v‹W« m¿ªJ bfh©nl‹. 
ïªj MŒî r«gªjkhfnth, ïij rh®ªj nkY« MŒî nk‰bfhŸS« 
nghJ« ïªj MŒÉš g§FbgW« kU¤Jt® v‹Dila kU¤Jt m¿¡iffis 
gh®¥gj‰F v‹ mDkâ njitÆšiy vd m¿ªJ bfhŸ»nw‹. eh‹ MŒÉš 
ïUªJ Éy»¡ bfh©lhY« ïJ bghUªJ« vd m¿»nw‹.  
ïªj MŒÉ‹ _y« »il¡F« jftšfisí«, gÇnrhjid 
Koîfisí« k‰W« á»¢ir bjhl®ghd jftšfisí« kU¤Jt® 
nk‰bfhŸS« MŒÉš ga‹gL¤â¡bfhŸsî« mij ãuRÇ¡fî« v‹ KG 
kdJl‹ r«kâ¡»‹nw‹.  
ïªj MŒÉš g§F bfhŸs x¥ò¡bfhŸ»nw‹. vd¡F bfhL¡f¥g£l 
m¿îiufË‹go elªJ bfhŸtJl‹ `ïªj MŒit nk‰bfhŸS« 
kU¤Jt mÂ¡F c©ikíl‹ ïU¥ng‹ v‹W cWâaË»nw‹.  
 
 
g§nf‰gtÇ‹ ifbah¥g« ……..……….. ïl«…………….. njâ…………… 
f£ilÉuš nuif 
g§nf‰gtÇ‹ bga® k‰W« Éyhr« …………………………………………… 
MŒthsÇ‹ ifbah¥g« ……………….. ïl«…………….. njâ……………. 
MŒthsÇ‹ bga® ………………………………………… 
MuhŒ¢á jftš jhŸ 
MuhŒ¢á jiy¥ò 
ánrÇa‹ mWit á»¢ir¡F¥ã‹ tÈÆšyhkš ïU¥gj‰F 
ouh‹°bt®° m¥lhÄd° ãns‹ ãsh¡ _y« òãbtbfŒ‹ mšyJ 
nuhãbtbfŒ‹ kUªâid x¥ãLjš 
MuhŒ¢áahs® bga® : kU¤Jt®.F.Ã¤ah 
g§nf‰ghs®  bga®  : 
MuhŒ¢áÆ‹ neh¡f« 
ánrÇa‹ mWit á»¢ir¡F¥ã‹ tÈÆšyhkš ïU¥gj‰F 
ouh‹°bt®° m¥lhÄd° ãns‹ ãsh¡ _y« òãbtbfŒ‹ mšyJ 
nuhãbtbfŒ‹ kUªâid x¥ãLjš 
1) nkny F¿¥ã£LŸs kUªJfË‹ kw¤J¥nghF« j‹ik 
mtfhr¤ij x¥ãLjš 
2) mWit á»¢ir¡F¥ã‹ ïu¤j mG¤j« k‰W« eho¤Jo¥ò 
kh‰w§fŸ 
3) mWit á»¢ir¡F¥ãªija tÈ Ãthuz« msî (ÉRtš mdyh¡ 
msînfhš) 
4) á¡fšfŸ É»j« 
5) mWit á»¢ir¡F¥ã‹ Kj‹Kiw tÈ ÃthuÂ njit¥gL« 
neu«. 
MŒî Kiw 
MŒÉš g§FbgW« nehahËfŸ _‹W FG¡fshf¥ ãÇ¡f¥gLt®. 
FG-1 mWit á»¢ir¡F¥ã‹ tÆ‰¿š ouh‹°bt®° m¥lhÄd° 
ãsh¡ _y« eh®kš riy‹ bfhL¡f¥gL«. 
FG-2 mWit á»¢ir¡F¥ã‹ tÆ‰¿š ouh‹°bt®° m¥lhÄd° 
ãsh¡ _y« óãbtbfŒ‹ 0.25% bfhL¡f¥gL«. 
FG-3 mWit á»¢ir¡F¥ã‹ tÆ‰¿š ouh‹°bt®° m¥lhÄd° 
ãsh¡ _y« nuhãbtbfŒ‹ 0.5% bfhL¡f¥gL«. 
 
e‹ikfŸ 
1) mWit á»¢irÆ‹nghJ eho¤Jo¥ò k‰W« ïu¤j mG¤j« Óuhf 
brašgl cjî»‹wd. 
2) ïju tÈ ÃthuÂfË‹ njit btFthf Fiw¡f¥gL»‹wd. 
3) mWit á»¢ir¡F¥ ã‹d® tÈ Ãthuz¤â‹ j‹ik 
Ú£o¡f¥gL»‹wJ. 
g¡fÉisîfŸ 
Cá nghL«nghJ mbrsfÇa« V‰glyh«. ku¤J¥nghF« CáÆ‹ 
_y« ïJ jÉ®¡f¥gL«. Fiwªj ïu¤j mG¤j«, Fiwªj eho¤Jo¥ò 
V‰glyh«. mj‰F kh‰W kUªJfŸ cldoahf bfhL¡f¥gL«. 
ïªj Kiwahd MŒî V‰fdnt gy ïl§fËš el¤j¥g£LŸsJ. 
nkY« ïj‹ ghJfh¥ò cWâbrŒa¥g£LŸsJ. Ú§fŸ ïªj MŒÉš 
g§FbfhŸs ÉU«gÉšiy v‹whš v¥nghJ« cgnah»¡f¥gL« kUªnj 
bfhL¡f¥gL«. c§fŸ ghJfh¥ng v§fË‹ K¡»a neh¡f«. 
ïªj MŒî r«gªjkhd všyh òŸË Étu§fŸ k‰W« 
nehahËfË‹ Étu§fŸ ufáakhf it¡f¥gL«. ïªj MŒî r«gªj¥g£l 
všyh gÇnrhjidfŸ, kUªJfŸ k‰W« kU¤Jt nritfŸ mid¤J« 
nehahËfS¡F ïytrkhf tH§f¥gL«. 
 
MŒthsÇ‹ bga® g§FbgWgtÇ‹ bga® 
 
MŒthsÇ‹ ifbah¥g« g§FbgWgtÇ‹ ifbah¥g« 
21 
 
 
 
 
 
 
 
 
 
22 
 
 
Submission author:
Assignment t it le:
Submission tit le:
File name:
File size:
Page count:
Word count:
Character count:
Submission date:
Submission ID:
Digital Receipt
This receipt acknowledges that Turnit in received your paper. Below you will f ind the receipt
inf ormation regarding your submission.
The f irst page of  your submissions is displayed below.
201420007 Md Anes G.NITHYA
2015-2015 plagiarism
BILATERAL TRANSVERSE ABDOM…
plagiarism_new.docx
1.88M
81
8,991
51,248
19-Sep-2016 10:50PM
706909402
Copyright 2016 Turnitin. All rights reserved.
